Your browser doesn't support javascript.
loading
Response to: "Commentary on: phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's disease: a retrospective cohort study".
Durukan, Emil; Jensen, Christian Fuglesang Skjødt; Fode, Mikkel.
Afiliação
  • Durukan E; Department of Urology, Copenhagen University Hospital, Herlev and Gentofte Hospital, Herlev, Denmark. emil.durukan.01@regionh.dk.
  • Jensen CFS; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. emil.durukan.01@regionh.dk.
  • Fode M; Department of Urology, Copenhagen University Hospital, Herlev and Gentofte Hospital, Herlev, Denmark.
Int J Impot Res ; 36(3): 297-298, 2024 May.
Article em En | MEDLINE | ID: mdl-38519589

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int J Impot Res Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int J Impot Res Ano de publicação: 2024 Tipo de documento: Article